What is the share price of Natural Capsules Ltd (NATCAPSUQ) today?
The share price of NATCAPSUQ as on 4th July 2025 is ₹218.79. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Natural Capsules Ltd (NATCAPSUQ) share?
The past returns of Natural Capsules Ltd (NATCAPSUQ) share are- Past 1 week: -5.71%
- Past 1 month: -6.46%
- Past 3 months: 5.90%
- Past 6 months: -21.83%
- Past 1 year: -30.21%
- Past 3 years: -53.12%
- Past 5 years: 456.01%
What are the peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ)?
The peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ) include:What is the market cap of Natural Capsules Ltd (NATCAPSUQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Natural Capsules Ltd (NATCAPSUQ) is ₹226.25 Cr as of 4th July 2025.What is the 52 week high and low of Natural Capsules Ltd (NATCAPSUQ) share?
The 52-week high of Natural Capsules Ltd (NATCAPSUQ) is ₹376.90 and the 52-week low is ₹164.What is the PE and PB ratio of Natural Capsules Ltd (NATCAPSUQ) stock?
The P/E (price-to-earnings) ratio of Natural Capsules Ltd (NATCAPSUQ) is 370.91. The P/B (price-to-book) ratio is 0.99.Which sector does Natural Capsules Ltd (NATCAPSUQ) belong to?
Natural Capsules Ltd (NATCAPSUQ) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Natural Capsules Ltd (NATCAPSUQ) shares?
You can directly buy Natural Capsules Ltd (NATCAPSUQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Natural Capsules Ltd
NATCAPSUQ Share Price
NATCAPSUQ Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
NATCAPSUQ Performance & Key Metrics
NATCAPSUQ Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
370.91 | 0.99 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.15 | 6.59 | 0.82% |
NATCAPSUQ Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
NATCAPSUQ Company Profile
Natural Capsules Limited makes hard gelatin capsule shells, hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.
NATCAPSUQ Sentiment Analysis
NATCAPSUQ Sentiment Analysis
NATCAPSUQ Stock Summary · June 2025
The company is poised for growth in the HPMC capsule segment, particularly in the U.S. market, driven by favorable tariff conditions and a projected revenue increase from Rs. 9 crores to Rs. 27 crores in FY'26. However, it faces significant challenges, including an 88.88% decline in profit after tax for FY'25 and operational difficulties reflected in a 12.01% drop in EBITDA. While regulatory approvals are underway to enhance market positioning, the API segment grapples with pricing pressures due to overcapacity in China. Despite these hurdles, management remains optimistic about improving profitability through strategic investments and capacity enhancements, aiming for a 10% to 15% overall revenue growth.
NATCAPSUQ Stock Growth Drivers
NATCAPSUQ Stock Growth Drivers
7HPMC Capsule Business Growth
The company has successfully established its HPMC capsule business, demonstrating stability and growth potential. In
Operational Capacity and Efficiency Improvements
The company has achieved full capacity utilization in its API facility, which is expected to
NATCAPSUQ Stock Challenges
NATCAPSUQ Stock Challenges
4Declining Profitability
The company reported a significant decline in profitability, with profit after tax for Q4 FY'25
Challenges in API Market
The company faces significant challenges in the API market, including a notable decline in API
NATCAPSUQ Forecast
NATCAPSUQ Forecasts
NATCAPSUQ
NATCAPSUQ
Income
Balance Sheet
Cash Flow
NATCAPSUQ Income Statement
NATCAPSUQ Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 55.57 | 60.92 | 62.50 | 82.42 | 136.08 | 172.94 | 157.36 | 169.91 | 169.91 | |||||||||
Raw Materials | 23.54 | 22.80 | 27.92 | 36.10 | 57.99 | 83.86 | 85.48 | 151.69 | 151.69 | |||||||||
Power & Fuel Cost | 6.79 | 8.89 | 8.16 | 8.51 | 11.90 | 13.75 | 15.19 | |||||||||||
Employee Cost | 5.23 | 5.57 | 5.91 | 6.97 | 8.48 | 9.51 | 11.00 | |||||||||||
Selling & Administrative Expenses | 9.47 | 8.89 | 8.99 | 9.76 | 16.95 | 23.00 | 17.80 | |||||||||||
Operating & Other expenses | 4.19 | 8.97 | 5.13 | 7.08 | 14.25 | 6.89 | 5.89 | |||||||||||
EBITDA | 6.35 | 5.80 | 6.39 | 14.00 | 26.51 | 35.93 | 22.00 | 18.22 | 18.22 | |||||||||
Depreciation/Amortization | 4.33 | 3.20 | 4.12 | 4.31 | 5.04 | 7.21 | 8.67 | 9.12 | 9.12 | |||||||||
PBIT | 2.02 | 2.60 | 2.27 | 9.69 | 21.47 | 28.72 | 13.33 | 9.10 | 9.10 | |||||||||
Interest & Other Items | 0.33 | 0.53 | 0.91 | 0.54 | 2.08 | 3.73 | 5.27 | 6.31 | 6.32 | |||||||||
PBT | 1.69 | 2.07 | 1.36 | 9.15 | 19.39 | 24.99 | 8.06 | 2.79 | 2.78 | |||||||||
Taxes & Other Items | 0.57 | 0.14 | 0.52 | 2.24 | 5.47 | 6.55 | 2.50 | 2.18 | 2.17 | |||||||||
Net Income | 1.12 | 1.93 | 0.84 | 6.91 | 13.92 | 18.44 | 5.56 | 0.61 | 0.61 | |||||||||
EPS | 1.47 | 2.54 | 1.11 | 9.09 | 19.05 | 22.64 | 5.97 | 0.22 | 0.65 | |||||||||
DPS | 0.82 | 0.82 | 0.49 | 0.82 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | |||||||||
Payout ratio | 0.56 | 0.32 | 0.45 | 0.09 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 |
NATCAPSUQ Company Updates
Investor Presentation
NATCAPSUQ Stock Peers
NATCAPSUQ Past Performance & Peer Comparison
NATCAPSUQ Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Natural Capsules Ltd | 370.91 | 0.99 | — |
Sun Pharmaceutical Industries Ltd | 36.80 | 5.99 | 0.95% |
Cipla Ltd | 23.18 | 3.91 | 1.06% |
Torrent Pharmaceuticals Ltd | 59.65 | 16.63 | 0.95% |
NATCAPSUQ Stock Price Comparison
Compare NATCAPSUQ with any stock or ETFNATCAPSUQ Holdings
NATCAPSUQ Shareholdings
NATCAPSUQ Promoter Holdings Trend
NATCAPSUQ Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NATCAPSUQ Institutional Holdings Trend
NATCAPSUQ Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
NATCAPSUQ Shareholding Pattern
NATCAPSUQ Shareholding Pattern
NATCAPSUQ Shareholding History
NATCAPSUQ Shareholding History
smallcases containing NATCAPSUQ stock
smallcases containing NATCAPSUQ stock
Looks like this stock is not in any smallcase yet.
NATCAPSUQ Events
NATCAPSUQ Events
NATCAPSUQ Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
NATCAPSUQ Dividend Trend
No dividend trend available
NATCAPSUQ Upcoming Dividends
NATCAPSUQ Upcoming Dividends
No upcoming dividends are available
NATCAPSUQ Past Dividends
NATCAPSUQ Past Dividends
Cash Dividend
Ex DateEx DateJul 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
Cash Dividend
Ex DateEx DateSep 9, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 9, 2022
Cash Dividend
Ex DateEx DateJul 6, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Jul 6, 2021
Cash Dividend
Ex DateEx DateAug 12, 2020
Dividend/Share
₹0.60
Ex DateEx Date
Aug 12, 2020
Cash Dividend
Ex DateEx DateAug 13, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Aug 13, 2019
NATCAPSUQ Stock News & Opinions
NATCAPSUQ Stock News & Opinions
Net profit of Natural Capsules declined 46.39% to Rs 0.52 crore in the quarter ended March 2025 as against Rs 0.97 crore during the previous quarter ended March 2024. Sales rose 11.81% to Rs 44.97 crore in the quarter ended March 2025 as against Rs 40.22 crore during the previous quarter ended March 2024. For the full year,net profit declined 88.83% to Rs 0.62 crore in the year ended March 2025 as against Rs 5.55 crore during the previous year ended March 2024. Sales rose 8.87% to Rs 169.21 crore in the year ended March 2025 as against Rs 155.42 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales44.9740.22 12 169.21155.42 9 OPM %9.7610.22 -10.3512.81 - PBDT3.053.63 -16 11.9116.72 -29 PBT0.891.43 -38 2.798.05 -65 NP0.520.97 -46 0.625.55 -89 Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
Net profit of Natural Capsules declined 90.91% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 1.21 crore during the previous quarter ended December 2023. Sales rose 9.63% to Rs 43.83 crore in the quarter ended December 2024 as against Rs 39.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales43.8339.98 10 OPM %9.7411.81 - PBDT2.843.98 -29 PBT0.501.79 -72 NP0.111.21 -91 Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Net loss of Natural Capsules reported to Rs 0.61 crore in the quarter ended September 2024 as against net profit of Rs 1.56 crore during the previous quarter ended September 2023. Sales rose 9.86% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 37.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales41.2237.52 10 OPM %10.9213.65 - PBDT2.964.31 -31 PBT0.622.14 -71 NP-0.611.56 PL Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live
Net profit of Natural Capsules declined 67.03% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales rose 3.93% to Rs 39.18 crore in the quarter ended June 2024 as against Rs 37.70 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales39.1837.70 4 OPM %11.1315.81 - PBDT3.054.80 -36 PBT0.772.69 -71 NP0.601.82 -67 Powered by Capital Market - Live
Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 August 2024 .Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 22.14%, vs industry avg of 10.14%
Over the last 5 years, market share increased from 0.02% to 0.04%
Over the last 5 years, net income has grown at a yearly rate of -6.2%, vs industry avg of 20.01%